Distress Related to the Feeling of Loss of Dignity in Patients With Rheumatic Diseases
Association Between the Presence of Distress Related to the Feeling of Loss of Dignity and Quality of Life in Patients With Rheumatic Diseases
1 other identifier
observational
309
1 country
1
Brief Summary
Rheumatic diseases (RD) are an important group of different clinical entities and specific diseases that affect a significant proportion of the world population. In Mexico, the RD have a relevant representation in the adult population. Dignity is a construct characterized by the representation of the self, of the self from others' point of view, and of the interaction of the individual with the environment and social context. Living with a chronic illness can threaten experiences of dignity for the sick person and their families. Various studies have demonstrated the direct impact of the disease on dignity in terms of physical and psychological symptoms and loss of function. Some efforts have been made to operationalize the concept of perceived dignity in the context of chronic diseases The perceived dignity of patients and the distress related to the feeling of loss of dignity (DRFLD) are outcomes that the patient can report and that the doctors can evaluate to be incorporated into the considerations of comprehensive care. Both outcomes are closely related, perceived dignity refers to a complex phenomenon, while distress related to the feeling of loss of dignity identifies those patients with a perceived dignity compromise of such magnitude that it generates anguish.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2022
CompletedFirst Posted
Study publicly available on registry
February 21, 2022
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedApril 6, 2022
February 1, 2022
1 year
January 30, 2022
April 4, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Determine the prevalence (percentage) of the presence of distress related to the feeling of loss of dignity in patients with RD
Determine the prevalence (percentage) of the presence of distress related to the feeling of loss of dignity in patients with RD, using PDI (distress related to the feeling of loss of dignity) instrument
Baseline (At study inclusion)
Secondary Outcomes (1)
Determine the quality of life in patients with RD, using WHOQOL-BREF (quality of life) instrument
Baseline (At study inclusion)
Study Arms (1)
Rheumatic diseases patients
All the rheumatic diseases outpatients from the National Institute of Medical Sciences
Interventions
The PDI is an instrument made up of 25 items integrated into 5 factors that include: symptoms, existential anguish, dependency, peace of mind, and social support, prior to its application, adaptation, and validation will performer
The WHOQOL-BREF is a self-report questionnaire which assesses 4 domains of quality of life (QOL): physical health, psychological health, social relationships, and environment, it consists of 24 items.
Eligibility Criteria
All the rheumatic diseases from the National Institute of Medical Sciences and Nutrition
You may qualify if:
- Patients with a rheumatic disease diagnosis according to their primary rheumatologist who agree to participate
You may not qualify if:
- Patients with a not confirmed rheumatic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Mexico City, 14080, Mexico
Related Publications (1)
Pascual-Ramos V, Contreras-Yanez I, Cuevas-Montoya M, Guaracha-Basanez G, Garcia-Alanis M, Rodriguez-Mayoral O, Chochinov HM. The impact of underlying RMD diagnosis on dignity landscape in patients with systemic lupus erythematosus, rheumatoid arthritis, and systemic sclerosis. Medicine (Baltimore). 2025 Jul 18;104(29):e43303. doi: 10.1097/MD.0000000000043303.
PMID: 40696675DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 30, 2022
First Posted
February 21, 2022
Study Start
March 1, 2022
Primary Completion
March 1, 2023
Study Completion
March 1, 2023
Last Updated
April 6, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share